MAPT and Alzheimer disease: The classical pathological hallmarks of AD, amyloid-β plaques and tau neurofibrillary tangles, remain central to diagnosis and therapeutic targeting, yet their precise roles in driving cognitive decline are incompletely understood [3, 31].